These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12271449)

  • 1. Liquid chromatography/tandem mass spectrometry for the determination of fluoxetine and its main active metabolite norfluoxetine in human plasma with deuterated fluoxetine as internal standard.
    Li C; Ji Z; Nan F; Shao Q; Liu P; Dai J; Zhen J; Yuan H; Xu F; Cui J; Huang B; Zhang M; Yu C
    Rapid Commun Mass Spectrom; 2002; 16(19):1844-50. PubMed ID: 12271449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple method to monitor serum concentrations of fluoxetine and its major metabolite for pharmacokinetic studies.
    Franceschi L; Faggiani A; Furlanut M
    J Pharm Biomed Anal; 2009 Feb; 49(2):554-7. PubMed ID: 19117710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous analysis of olanzapine, fluoxetine, and norfluoxetine in human plasma using liquid chromatography-mass spectrometry and its application to a pharmacokinetic study.
    Ni XJ; Wang ZZ; Shang DW; Lu HY; Zhang M; Wen YG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():506-514. PubMed ID: 30008307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A validated enantioselective assay for the simultaneous quantitation of (R)-, (S)-fluoxetine and (R)-, (S)-norfluoxetine in ovine plasma using liquid chromatography with tandem mass spectrometry (LC/MS/MS).
    Chow TW; Szeitz A; Rurak DW; Riggs KW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Feb; 879(5-6):349-58. PubMed ID: 21242112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous identification and quantitation of fluoxetine and its metabolite, norfluoxetine, in biological samples by GC-MS.
    Crifasi JA; Le NX; Long C
    J Anal Toxicol; 1997 Oct; 21(6):415-9. PubMed ID: 9323519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enantiomeric separation and quantification of fluoxetine (Prozac) in human plasma by liquid chromatography/tandem mass spectrometry using liquid-liquid extraction in 96-well plate format.
    Shen Z; Wang S; Bakhtiar R
    Rapid Commun Mass Spectrom; 2002; 16(5):332-8. PubMed ID: 11857715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of fluoxetine and its major active metabolite norfluoxetine in human plasma by LC-MS/MS using supported liquid extraction.
    Li Y; Emm T; Yeleswaram S
    Biomed Chromatogr; 2011 Nov; 25(11):1245-51. PubMed ID: 21308704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of second-generation antidepressant drug, sertraline and its active metabolite, N-desmethyl sertraline in human plasma by a sensitive and selective liquid chromatography-tandem mass spectrometry method.
    Patel BN; Sharma N; Sanyal M; Shrivastav PS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jan; 877(3):221-9. PubMed ID: 19109078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of paroxetine in plasma by liquid chromatography coupled to tandem mass spectrometry for pharmacokinetic and bioequivalence studies.
    Jhee OH; Seo HK; Lee MH; Jeon YC; Shaw LM; Lee SH; Hur Y; Kim KH; Lee HS; Lee SE; Kang JS
    Arzneimittelforschung; 2007; 57(7):455-61. PubMed ID: 17803058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-phase, liquid-phase microextraction combined with high performance liquid chromatography-fluorescence detection for the simultaneous determination of fluoxetine and norfluoxetine in human plasma.
    de Freitas DF; Porto CE; Vieira EP; de Siqueira ME
    J Pharm Biomed Anal; 2010 Jan; 51(1):170-7. PubMed ID: 19683889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoxetine bioequivalence study: quantification of fluoxetine and norfluoxetine by liquid chromatography coupled to mass spectrometry.
    Moraes MO; Lerner FE; Corso G; Bezerra FA; Moraes ME; De Nucci G
    J Clin Pharmacol; 1999 Oct; 39(10):1053-61. PubMed ID: 10516940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid analysis of fluoxetine and its metabolite in plasma by LC-MS with column-switching approach.
    Souverain S; Mottaz M; Cherkaoui S; Veuthey JL
    Anal Bioanal Chem; 2003 Nov; 377(5):880-5. PubMed ID: 12955393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rapid HPLC-DAD method for the analysis of fluoxetine and norfluoxetine in plasma from overdose patients.
    Sabbioni C; Bugamelli F; Varani G; Mercolini L; Musenga A; Saracino MA; Fanali S; Raggi MA
    J Pharm Biomed Anal; 2004 Oct; 36(2):351-6. PubMed ID: 15496328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unsuspected poor metabolizer phenotypes of fluoxetine in bioavailability/bioequivalence studies from an indian population perspective. Retrospective pharmacokinetic data evaluation.
    Kandasamy M; Tripathy K; Ravi S; Kamath N; Pai B; Srinivas NR; Kristjansson F; Thangam S
    Arzneimittelforschung; 2010; 60(1):12-21. PubMed ID: 20184222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitive liquid chromatographic-tandem mass spectrometric method for the determination of fluoxetine and its primary active metabolite norfluoxetine in human plasma.
    Sutherland FC; Badenhorst D; de Jager AD; Scanes T; Hundt HK; Swart KJ; Hundt AF
    J Chromatogr A; 2001 Apr; 914(1-2):45-51. PubMed ID: 11358229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trace analysis of fluoxetine and its metabolite norfluoxetine. Part I: development of a chiral liquid chromatography-tandem mass spectrometry method for wastewater samples.
    Barclay VK; Tyrefors NL; Johansson IM; Pettersson CE
    J Chromatogr A; 2011 Aug; 1218(33):5587-96. PubMed ID: 21752386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid and direct measurement of free concentrations of highly protein-bound fluoxetine and its metabolite norfluoxetine in plasma.
    Guo B; Li C; Wang G; Chen L
    Rapid Commun Mass Spectrom; 2006; 20(1):39-47. PubMed ID: 16308873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of liquid chromatography with fluorescence detection to liquid chromatography-mass spectrometry for the determination of fluoxetine and norfluoxetine in human plasma.
    Kovacevic I; Pokrajac M; Miljkovic B; Jovanovic D; Prostran M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(2):372-6. PubMed ID: 16356789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of mianserin in human plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-ESI/MS): application to a bioequivalence study in Chinese volunteers.
    Xu P; Li HD; Chen BM; Ma N; Yan M; Zhu YG
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):994-9. PubMed ID: 18514457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitive and selective liquid-chromatographic assay of fluoxetine and norfluoxetine in plasma with fluorescence detection after precolumn derivatization.
    Suckow RF; Zhang MF; Cooper TB
    Clin Chem; 1992 Sep; 38(9):1756-61. PubMed ID: 1526010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.